Suspected non-AD pathology in mild cognitive impairment

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2015
Source ID
10.1016/j.neurobiolaging.2015.08.029

Entities

People

  • Bradford C. Dickerson
  • Christos Davatzikos
  • David A. Wolk
  • Laura E.m. Wisse
  • Nirali Butala
  • Paul A. Yushkevich
  • Sandhitsu R. Das
  • Sanjeev N. Vaishnavi

Organizations

  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Medpace
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense